Clinical trial NCT01061567: Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice
Official title: Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Parkinson's Disease
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2010-02-03
Enrollment: 1814
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients

Brief summary: The general aim of this non-interventional study is to assess the safety and efficacy of pramipexole extended release in patients with Parkinson's disease in routine clinical practice.


Eligibility criteria: Inclusion criteria:

* Early and advanced idiopathic Parkinson's disease
* Male and female patients over 18 years of age
* Indication for treatment with pramipexole ER according to Summary of Product Characteristics (SmPC)

Exclusion criteria:

* Ongoing treatment with pramipexole ER
* Exclusion criteria in line with the pramipexole ER SmPC:

In particular hypersensitivity to pramipexole or to any of the excipients and pregnancy and lactation as stated in the SmPC.

Primary outcomes:
measure: Incidence of Adverse Events
timeFrame: From the treatment initiation to the end of study, on average 92.9 days
measure: Proportion of Patients With Withdrawals Due to Adverse Events.
timeFrame: 16 weeks
Secondary outcomes:
measure: Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Parts I and III Total Score
timeFrame: Baseline and the end of study (up to 16 weeks)
measure: Clinical Global Impression of Improvement (CGI-I) Responder Rate
timeFrame: Baseline and the end of study (up to 16 weeks)
measure: Change From Baseline in Visual Analogue Scale (VAS) of Patient Satisfaction
timeFrame: Baseline and the end of study (up to 16 weeks)
measure: Change From Baseline in Morisky Medication Adherence Scale (MMAS) 4 Item Score
timeFrame: Baseline and the end of study (up to 16 weeks)
Other outcomes:
Locations:
city: Bad Ischl
country: Austria
facility: Boehringer Ingelheim Investigational Site 1
city: Bad Radkersburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 2
city: Baden
country: Austria
facility: Boehringer Ingelheim Investigational Site 3
city: Baden
country: Austria
facility: Boehringer Ingelheim Investigational Site 4
city: Bludenz
country: Austria
facility: Boehringer Ingelheim Investigational Site 5
city: Braunau/Inn
country: Austria
facility: Boehringer Ingelheim Investigational Site 6
city: Deutschlandsberg
country: Austria
facility: Boehringer Ingelheim Investigational Site 7
city: Dornbirn
country: Austria
facility: Boehringer Ingelheim Investigational Site 8
city: Dornbirn
country: Austria
facility: Boehringer Ingelheim Investigational Site 9
city: Ehenbichl
country: Austria
facility: Boehringer Ingelheim Investigational Site 10
city: Eisenstadt
country: Austria
facility: Boehringer Ingelheim Investigational Site 11
city: Eisenstadt
country: Austria
facility: Boehringer Ingelheim Investigational Site 12
city: Feldbach
country: Austria
facility: Boehringer Ingelheim Investigational Site 13
city: Feldkirchen
country: Austria
facility: Boehringer Ingelheim Investigational Site 14
city: Graz
country: Austria
facility: Boehringer Ingelheim Investigational Site 16
city: Graz
country: Austria
facility: Boehringer Ingelheim Investigational Site 17
city: Graz
country: Austria
facility: Boehringer Ingelheim Investigational Site 18
city: Graz
country: Austria
facility: Boehringer Ingelheim Investigational Site 19
city: Grieskirchen
country: Austria
facility: Boehringer Ingelheim Investigational Site 20
city: Grimmenstein
country: Austria
facility: Boehringer Ingelheim Investigational Site 21
city: Gänserndorf
country: Austria
facility: Boehringer Ingelheim Investigational Site 15
city: Hainburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 22
city: Hall/Tirol
country: Austria
facility: Boehringer Ingelheim Investigational Site 23
city: Hallein
country: Austria
facility: Boehringer Ingelheim Investigational Site 24
city: Hartberg
country: Austria
facility: Boehringer Ingelheim Investigational Site 25
city: Hermagor
country: Austria
facility: Boehringer Ingelheim Investigational Site 26
city: Hohenems
country: Austria
facility: Boehringer Ingelheim Investigational Site 27
city: Horn
country: Austria
facility: Boehringer Ingelheim Investigational Site 28
city: Horn
country: Austria
facility: Boehringer Ingelheim Investigational Site 29
city: Imst
country: Austria
facility: Boehringer Ingelheim Investigational Site 30
city: Innsbruck
country: Austria
facility: Boehringer Ingelheim Investigational Site 31
city: Innsbruck
country: Austria
facility: Boehringer Ingelheim Investigational Site 32
city: Innsbruck
country: Austria
facility: Boehringer Ingelheim Investigational Site 33
city: Judenburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 34
city: Kapfenberg
country: Austria
facility: Boehringer Ingelheim Investigational Site 35
city: Klagenfurt
country: Austria
facility: Boehringer Ingelheim Investigational Site 36
city: Klagenfurt
country: Austria
facility: Boehringer Ingelheim Investigational Site 37
city: Klagenfurt
country: Austria
facility: Boehringer Ingelheim Investigational Site 38
city: Klagenfurt
country: Austria
facility: Boehringer Ingelheim Investigational Site 39
city: Knittelfeld
country: Austria
facility: Boehringer Ingelheim Investigational Site 40
city: Krems
country: Austria
facility: Boehringer Ingelheim Investigational Site 41
city: Kufstein
country: Austria
facility: Boehringer Ingelheim Investigational Site 42
city: Laßnitzhöhe
country: Austria
facility: Boehringer Ingelheim Investigational Site 43
city: Leibnitz
country: Austria
facility: Boehringer Ingelheim Investigational Site 44
city: Leoben
country: Austria
facility: Boehringer Ingelheim Investigational Site 45
city: Lienz
country: Austria
facility: Boehringer Ingelheim Investigational Site 46
city: Lienz
country: Austria
facility: Boehringer Ingelheim Investigational Site 47
city: Lilienfeld
country: Austria
facility: Boehringer Ingelheim Investigational Site 48
city: Linz
country: Austria
facility: Boehringer Ingelheim Investigational Site 49
city: Linz
country: Austria
facility: Boehringer Ingelheim Investigational Site 50
city: Melk
country: Austria
facility: Boehringer Ingelheim Investigational Site 51
city: Mürzzuschlag
country: Austria
facility: Boehringer Ingelheim Investigational Site 52
city: Neulengbach
country: Austria
facility: Boehringer Ingelheim Investigational Site 53
city: Neulengbach
country: Austria
facility: Boehringer Ingelheim Investigational Site 54
city: Neunkirchen
country: Austria
facility: Boehringer Ingelheim Investigational Site 55
city: Neunkirchen
country: Austria
facility: Boehringer Ingelheim Investigational Site 56
city: Neusiedl am See
country: Austria
facility: Boehringer Ingelheim Investigational Site 57
city: Oberwart
country: Austria
facility: Boehringer Ingelheim Investigational Site 58
city: Oberwart
country: Austria
facility: Boehringer Ingelheim Investigational Site 59
city: Oberwart
country: Austria
facility: Boehringer Ingelheim Investigational Site 60
city: Regelsbrunn
country: Austria
facility: Boehringer Ingelheim Investigational Site 61
city: Ried im Innkreis
country: Austria
facility: Boehringer Ingelheim Investigational Site 62
city: Ried im Innkreis
country: Austria
facility: Boehringer Ingelheim Investigational Site 63
city: Rohrbach
country: Austria
facility: Boehringer Ingelheim Investigational Site 64
city: Salzburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 65
city: Salzburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 66
city: Salzburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 67
city: Salzburg
country: Austria
facility: Boehringer Ingelheim Investigational Site 68
city: Scheibbs
country: Austria
facility: Boehringer Ingelheim Investigational Site 69
city: St. Johann im Pongau
country: Austria
facility: Boehringer Ingelheim Investigational Site 70
city: St. Pölten
country: Austria
facility: Boehringer Ingelheim Investigational Site 71
city: St. Pölten
country: Austria
facility: Boehringer Ingelheim Investigational Site 72
city: St. Veit an der Glan
country: Austria
facility: Boehringer Ingelheim Investigational Site 73
city: Telfs
country: Austria
facility: Boehringer Ingelheim Investigational Site 74
city: Tullnerbach-Lawies
country: Austria
facility: Boehringer Ingelheim Investigational Site 76
city: Tulln
country: Austria
facility: Boehringer Ingelheim Investigational Site 75
city: Villach-Warmbad
country: Austria
facility: Boehringer Ingelheim Investigational Site 79
city: Villach
country: Austria
facility: Boehringer Ingelheim Investigational Site 77
city: Villach
country: Austria
facility: Boehringer Ingelheim Investigational Site 78
city: Vöcklabruck
country: Austria
facility: Boehringer Ingelheim Investigational Site 80
city: Vöcklabruck
country: Austria
facility: Boehringer Ingelheim Investigational Site 81
city: Völkermarkt
country: Austria
facility: Boehringer Ingelheim Investigational Site 82
city: Wagna
country: Austria
facility: Boehringer Ingelheim Investigational Site 83
city: Wiener Neustadt
country: Austria
facility: Boehringer Ingelheim Investigational Site 108
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 100
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 101
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 102
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 103
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 104
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 105
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 106
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 107
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 84
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 85
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 86
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 87
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 88
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 89
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 90
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 91
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 92
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 93
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 94
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 95
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 96
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 97
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 98
city: Wien
country: Austria
facility: Boehringer Ingelheim Investigational Site 99
city: Wolfsberg
country: Austria
facility: Boehringer Ingelheim Investigational Site 109
city: Zirl
country: Austria
facility: Boehringer Ingelheim Investigational Site 110
city: Zwettl
country: Austria
facility: Boehringer Ingelheim Investigational Site 111
city: Järvamaa
country: Estonia
facility: Boehringer Ingelheim Investigational Site 115
city: Kohtla-Järve
country: Estonia
facility: Boehringer Ingelheim Investigational Site 114
city: Kuressaare
country: Estonia
facility: Boehringer Ingelheim Investigational Site 121
city: Rakvere
country: Estonia
facility: Boehringer Ingelheim Investigational Site 116
city: Tallinn
country: Estonia
facility: Boehringer Ingelheim Investigational Site 112
city: Tallinn
country: Estonia
facility: Boehringer Ingelheim Investigational Site 113
city: Tartu
country: Estonia
facility: Boehringer Ingelheim Investigational Site 117
city: Valga
country: Estonia
facility: Boehringer Ingelheim Investigational Site 118
city: Viimsi
country: Estonia
facility: Boehringer Ingelheim Investigational Site 119
city: Viljandi
country: Estonia
facility: Boehringer Ingelheim Investigational Site 120
city: Almaty
country: Kazakhstan
facility: Boehringer Ingelheim Investigational Site 283
city: Astana
country: Kazakhstan
facility: Boehringer Ingelheim Investigational Site 284
city: Shymkent
country: Kazakhstan
facility: Boehringer Ingelheim Investigational Site 282
city: Alba Iulia
country: Romania
facility: Boehringer Ingelheim Investigational Site 193
city: Bacau
country: Romania
facility: Boehringer Ingelheim Investigational Site 194
city: Bacau
country: Romania
facility: Boehringer Ingelheim Investigational Site 195
city: Bacau
country: Romania
facility: Boehringer Ingelheim Investigational Site 196
city: Baia Mare
country: Romania
facility: Boehringer Ingelheim Investigational Site 197
city: Baia Mare
country: Romania
facility: Boehringer Ingelheim Investigational Site 198
city: Botosani
country: Romania
facility: Boehringer Ingelheim Investigational Site 199
city: Brasov
country: Romania
facility: Boehringer Ingelheim Investigational Site 200
city: Brasov
country: Romania
facility: Boehringer Ingelheim Investigational Site 201
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 202
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 203
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 204
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 205
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 206
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 207
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 208
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 209
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 210
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 211
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 212
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 213
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 214
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 215
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 216
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 217
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 218
city: Bucuresti
country: Romania
facility: Boehringer Ingelheim Investigational Site 219
city: Buzau
country: Romania
facility: Boehringer Ingelheim Investigational Site 220
city: Buzau
country: Romania
facility: Boehringer Ingelheim Investigational Site 221
city: Campulung
country: Romania
facility: Boehringer Ingelheim Investigational Site 222
city: Cluj-Napoca
country: Romania
facility: Boehringer Ingelheim Investigational Site 223
city: Cluj-Napoca
country: Romania
facility: Boehringer Ingelheim Investigational Site 224
city: Constanta
country: Romania
facility: Boehringer Ingelheim Investigational Site 225
city: Constanta
country: Romania
facility: Boehringer Ingelheim Investigational Site 226
city: Constanta
country: Romania
facility: Boehringer Ingelheim Investigational Site 227
city: Craiova
country: Romania
facility: Boehringer Ingelheim Investigational Site 228
city: Craiova
country: Romania
facility: Boehringer Ingelheim Investigational Site 229
city: Craiova
country: Romania
facility: Boehringer Ingelheim Investigational Site 230
city: Craiova
country: Romania
facility: Boehringer Ingelheim Investigational Site 231
city: Craiova
country: Romania
facility: Boehringer Ingelheim Investigational Site 232
city: Curtea de Arges
country: Romania
facility: Boehringer Ingelheim Investigational Site 233
city: Focsani
country: Romania
facility: Boehringer Ingelheim Investigational Site 234
city: Focsani
country: Romania
facility: Boehringer Ingelheim Investigational Site 235
city: Galati
country: Romania
facility: Boehringer Ingelheim Investigational Site 236
city: Iasi
country: Romania
facility: Boehringer Ingelheim Investigational Site 237
city: Iasi
country: Romania
facility: Boehringer Ingelheim Investigational Site 238
city: Iasi
country: Romania
facility: Boehringer Ingelheim Investigational Site 239
city: Medgidia
country: Romania
facility: Boehringer Ingelheim Investigational Site 240
city: Oradea
country: Romania
facility: Boehringer Ingelheim Investigational Site 241
city: Oradea
country: Romania
facility: Boehringer Ingelheim Investigational Site 242
city: Piatra Neamt
country: Romania
facility: Boehringer Ingelheim Investigational Site 243
city: Piatra Neamt
country: Romania
facility: Boehringer Ingelheim Investigational Site 244
city: Pitesti
country: Romania
facility: Boehringer Ingelheim Investigational Site 245
city: Pitesti
country: Romania
facility: Boehringer Ingelheim Investigational Site 246
city: Ploiesti
country: Romania
facility: Boehringer Ingelheim Investigational Site 247
city: Prahova
country: Romania
facility: Boehringer Ingelheim Investigational Site 248
city: Radauti
country: Romania
facility: Boehringer Ingelheim Investigational Site 249
city: Ramnicu Valcea
country: Romania
facility: Boehringer Ingelheim Investigational Site 250
city: Ramnicu Valcea
country: Romania
facility: Boehringer Ingelheim Investigational Site 251
city: Ramnicu Valcea
country: Romania
facility: Boehringer Ingelheim Investigational Site 252
city: Satu Mare
country: Romania
facility: Boehringer Ingelheim Investigational Site 253
city: Satu Mare
country: Romania
facility: Boehringer Ingelheim Investigational Site 254
city: Sibiu
country: Romania
facility: Boehringer Ingelheim Investigational Site 255
city: Sibiu
country: Romania
facility: Boehringer Ingelheim Investigational Site 256
city: Simleul Silvaniei
country: Romania
facility: Boehringer Ingelheim Investigational Site 257
city: Slobozia
country: Romania
facility: Boehringer Ingelheim Investigational Site 258
city: Suceava
country: Romania
facility: Boehringer Ingelheim Investigational Site 259
city: Targoviste
country: Romania
facility: Boehringer Ingelheim Investigational Site 260
city: Targoviste
country: Romania
facility: Boehringer Ingelheim Investigational Site 261
city: Targu Mures
country: Romania
facility: Boehringer Ingelheim Investigational Site 262
city: Tarnaveni
country: Romania
facility: Boehringer Ingelheim Investigational Site 263
city: Tarnaveni
country: Romania
facility: Boehringer Ingelheim Investigational Site 264
city: Timisoara
country: Romania
facility: Boehringer Ingelheim Investigational Site 265
city: Timisoara
country: Romania
facility: Boehringer Ingelheim Investigational Site 266
city: Timisoara
country: Romania
facility: Boehringer Ingelheim Investigational Site 267
city: Timisoara
country: Romania
facility: Boehringer Ingelheim Investigational Site 268
city: Tulcea
country: Romania
facility: Boehringer Ingelheim Investigational Site 269
city: Tulcea
country: Romania
facility: Boehringer Ingelheim Investigational Site 270
city: Tulcea
country: Romania
facility: Boehringer Ingelheim Investigational Site 271
city: Turda
country: Romania
facility: Boehringer Ingelheim Investigational Site 272
city: Turnu Magurele
country: Romania
facility: Boehringer Ingelheim Investigational Site 273
city: Zalau
country: Romania
facility: Boehringer Ingelheim Investigational Site 274
city: Belgrade
country: Serbia
facility: Boehringer Ingelheim Investigational Site 275
city: Belgrade
country: Serbia
facility: Boehringer Ingelheim Investigational Site 276
city: Kragujevac
country: Serbia
facility: Boehringer Ingelheim Investigational Site 278
city: Kraljevo
country: Serbia
facility: Boehringer Ingelheim Investigational Site 281
city: Nis
country: Serbia
facility: Boehringer Ingelheim Investigational Site 279
city: Novi Sad
country: Serbia
facility: Boehringer Ingelheim Investigational Site 277
city: Uzice
country: Serbia
facility: Boehringer Ingelheim Investigational Site 280
city: Banská Bystrica
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 122
city: Bardejov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 123
city: Bardejov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 124
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 125
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 126
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 127
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 128
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 129
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 130
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 131
city: Bratislava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 132
city: Brezno
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 133
city: Detva
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 134
city: Dolný Kubín
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 135
city: Dolný Kubín
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 136
city: Hlohovec
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 137
city: Hlohovec
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 138
city: Humenné
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 139
city: Kezmarok
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 140
city: Kezmarok
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 141
city: Komárno
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 142
city: Kosice
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 143
city: Kosice
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 144
city: Kosice
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 145
city: Kosice
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 146
city: Kosice
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 147
city: Krompachy
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 148
city: Liptovský Mikulás
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 149
city: Lucenec
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 150
city: Lucenec
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 151
city: Lucenec
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 152
city: Martin
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 153
city: Martin
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 154
city: Myjava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 155
city: Nitra
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 157
city: Nitra
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 158
city: Nitra
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 159
city: Nitra
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 160
city: Námestovo
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 156
city: Pezinok
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 161
city: Piestany
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 162
city: Presov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 163
city: Presov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 164
city: Presov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 165
city: Presov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 166
city: Sahy
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 167
city: Sala
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 168
city: Skalica
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 169
city: Stará Lubovna
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 170
city: Surany
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 171
city: Topolcany
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 172
city: Trebisov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 173
city: Trencín
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 174
city: Trnava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 175
city: Trnava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 176
city: Trstená
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 177
city: Vranov nad Top?ou
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 178
city: Ziar nad Hronom
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 179
city: Zilina
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 180
city: Zlaté Moravce
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 182
city: Zvolen
country: Slovakia
facility: Boehringer Ingelheim Investigational Site 181
city: Celje
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 183
city: Lesce
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 184
city: Ljubljana
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 185
city: Ljubljana
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 186
city: Maribor
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 187
city: Maribor
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 188
city: Sempeter
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 190
city: Sempeter
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 191
city: Slovenj Gradec
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 189
city: Velenje
country: Slovenia
facility: Boehringer Ingelheim Investigational Site 192
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References: